| Literature DB >> 32456174 |
Kazim Sahin1, Cemal Orhan1, Osman Kucuk2, Nurhan Sahin1, Mehmet Tuzcu3, Besir Er3, Shane Durkee4, Aouatef Bellamine4.
Abstract
The objective of this work is to investigate the effects of Carnipure® Tartrate (CT) supplementation with or without exercise on endurance capacity, recovery, and fatigue by assessing time to exhaustion as well as body weight and composition in rats. In addition, antioxidant capacity has been evaluated by measuring malondialdehyde (MDA) levels and antioxidant enzyme (superoxide dismutase, SOD; catalase, CAT; glutathioneperoxidase; GSHPx) activities. Fifty-six male Wistar rats were divided into eight groups including seven rats each. A control group did not receive CT nor exercise. Another control group received 200 mg/kg CT without exercise. The other six groups of rats went through an exercise regimen consisting of a 5-day training period with incremental exercise capacity, which was followed by 6 weeks of the run at 25 m/min for 45 min every day. CT was supplemented at 0, 25, 50, 100, 200, and 400 mg/kg per day during the 6 weeks. Rats submitted to exercise and supplemented with CT had a significant and dose-dependent increase in time to exhaustion and this effect seems to be independent of exercise (p < 0.05). Additionally, recovery and fatigue were improved, as shown by a significant and dose-dependent decrease in myoglobin and lactic acid plasma levels, which are two markers of muscle recovery. CT supplementation led to a dose-response decrease in body weight and visceral fat. These effects become significant at 200 and 400 mg/kg doses (p < 0.05). Additionally, the antioxidant capacity was improved, as shown by a significant and dose-dependent increase in SOD, CAT, and GSHPx. Serum MDA concentrations decreased in exercising rats with CT supplementation. CT supplementation led to a decrease in serum glucose, triglycerides, and total cholesterol concentrations with the lowest levels observed at 400 mg/kg dose (p < 0.05). These effects correlated with a significant dose-dependent increase in serum total L-carnitine, free L-carnitine, and acetyl-carnitine, which linked the observed efficacy to CT supplementation. These results demonstrate that CT supplementation during exercise provides benefits on exercise performance, recovery, and fatigue as well as improved the lipid profile and antioxidant capacity. The lowest dose leads to some of these effects seen in rats where 25 mg/kg corresponds to 250 mg/day as a human equivalent.Entities:
Keywords: L-carnitine; body mass index; endurance; exercise; fatigue; metabolic parameters; recovery
Mesh:
Substances:
Year: 2020 PMID: 32456174 PMCID: PMC7284330 DOI: 10.3390/nu12051519
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Ingredient and nutrient composition of the basal diet fed to the rats.
| Ingredient | % |
|---|---|
| Maize | 26.00 |
| Wheat | 14.00 |
| Vegetable oil | 3.00 |
| Soybean meal, 48% CP 1 | 33.10 |
| Sunflower meal, 30% CP | 8.00 |
| Wheat bran | 7.00 |
| Molasses | 5.00 |
| Limestone | 0.80 |
| Salt | 0.80 |
| DL-Methionine | 0.80 |
| Dicalcium phosphate | 1.20 |
| Vitamin and mineral premix 2 | 0.30 |
| Analysis (%) | |
| Crude protein | 24.27 |
| Ether extract | 4.55 |
| Crude cellulose | 4.04 |
| Ash | 6.91 |
| Ca | 0.75 |
| P | 0.41 |
1 CP: Crude Protein. 2 The vitamin-mineral premix provides the following (per kg): all-trans-retinyl acetate, 1.8 mg, cholecalciferol, 0.025 mg, all-rac-a-tocopherol acetate, 12.5 mg; menadione (menadione sodium bisulfate), 1.1 mg, riboflavin, 4.4 mg, thiamine (thiamine mononitrate), 1.1 mg, vitamin B-6, 2.2 mg, niacin, 35 mg, Ca-pantothenate, 10 mg, vitamin B-12, 0.02 mg, folic acid, 0.55 mg, d-biotin, 0.1 mg. manganese (from manganese oxide), 40 mg, iron (from iron sulfate), 12.5 mg, zinc (from zinc oxide), 25 mg, copper (from copper sulfate), 3.5 mg, iodine (from potassium iodide), 0.3 mg, selenium (from sodium selenite), 0.15 mg; choline chloride, 175 mg.
Figure 1Effects of Carnipure tartrate supplementation on recovery parameters. The effects of Carnipure® tartrate on the exercise performance (A), lactic acid (B), and myoglobin (C) levels in exercised rats but also in non-exercised rats (groups C0 and C200). Statistical comparisons are indicated with a different superscript (a–g) in the plots (p < 0.05, ANOVA, and Turkey’s post-hoc test). The data in the box and whiskers graphics are presented as the median, minimum, and maximum values for each plot.
Figure 2Effects of Carnipure Tartrate supplementation on body weight and composition. The effects of Carnipure® tartrate on the body weight (A), body mass index (B) visceral fat (C), and Lee index (D) in exercised rats but also in non-exercised rats (groups C0 and C200). Statistical comparisons are indicated with different superscripts (a–g) in the plots (p < 0.05, ANOVA, and Tukey’s post-hoc test). The data in the box and whiskers graphics are presented as the median, minimum, and maximum values for each plot.
Antioxidant capacity.
| Items | Groups | |||||||
|---|---|---|---|---|---|---|---|---|
| Control | Car200 | Exercise (E) | E+Car25 | E+Car50 | E+Car100 | E+Car200 | E+Car400 | |
| MDA, µmol/L | 0.873 ± 0.017 a | 0.693 ± 0.021 b | 0.768 ± 0.015b | 0.599 ± 0.021 c | 0.549 ± 0.014 c,d | 0.553 ± 0.018 c,d | 0.489 ± 0.019 d,e | 0.419 ± 0.009 e |
| SOD, U/mg protein | 83.88 ± 2.21 e | 95.87 ± 2.47 c,d | 85.21 ± 2.99 d,e | 96.49 ± 0.78 c,d | 102.89 ± 2.69 b,c | 109.68 ± 2.49 a,b | 114.56 ± 2.70 a | 120.16 ± 3.58 a |
| CAT, U/mg protein | 135.51 ± 2.61 e | 147.19 ± 2.01 d,e | 138.47 ± 3.69 e | 144.55 ± 3.21 d,e | 152.72 ± 2.50 c,d | 162.11 ± 1.97 b,c | 170.77 ± 2.57 b | 186.10 ± 2.50 a |
| GSHPx, U/mg protein | 36.87 ± 1.27 f | 48.74 ± 1.11 d | 42.56 ± 1.43 e | 49.75 ± 1.08 d | 55.91 ± 0.85 c | 59.57 ± 0.68 b,c | 62.58 ± 1.03 b | 69.06 ± 1.53 a |
MDA: malondialdehyde. SOD: superoxide dismutase. CAT: catalase. GSH-Px: glutathione peroxidase. Statistical comparisons are indicated with different superscript (a–f) in the same row (p < 0.05, *ANOVA and Tukey’s post-hoc test).
Glucose and lipid levels.
| Items | Groups | |||||||
|---|---|---|---|---|---|---|---|---|
| Control | Car200 | Exercise (E) | E+Car25 | E+Car50 | E+Car100 | E+Car200 | E+Car400 | |
| GLU, mg/dL | 115.29 ± 2.01 a | 109.43 ± 1.25 a,b | 104.43 ± 1.32 b,c | 101.14 ± 1.97 c | 103.43 ± 1.46 b,c | 101.43 ± 1.36 c | 98.43 ± 1.32 c,d | 92.43 ± 1.25 d |
| TG, mg/dL | 172.86 ± 4.08 a | 165.00 ± 2.32 a,b | 156.14 ± 4.08 b,c | 150.57 ± 3.21 c | 135.29 ± 2.54 d | 124.43 ± 1.46 d,e | 120.14 ± 2.11 e | 113.43 ± 1.39 e |
| TC, mg/dL | 149.57 ± 2.10 a | 142.62 ± 1.45 b | 138.22 ± 0.67 b,c | 135.10 ± 0.56 c | 127.57 ± 1.25 d | 115.08 ± 0.62 e | 110.23 ± 0.78 e | 102.27 ± 1.50 f |
| BUN, mg/dL | 21.59 ± 0.82 | 21.40 ± 0.65 | 20.67 ± 0.45 | 21.23 ± 0.90 | 21.34 ± 0.85 | 21.60 ± 0.82 | 21.31 ± 1.06 | 21.41 ± 0.69 |
| TP, g/dL | 6.50 ± 0.18 | 6.49 ± 0.13 | 6.50 ± 0.23 | 6.13 ± 0.43 | 5.93 ± 0.29 | 6.07 ± 0.44 | 6.37 ± 0.18 | 6.29 ± 0.20 |
| TBIL, mg/dL | 0.23 ± 0.01 | 0.24 ± 0.01 | 0.23 ± 0.01 | 0.22 ± 0.01 | 0.22 ± 0.01 | 0.23 ± 0.01 | 0.24 ± 0.01 | 0.23 ± 0.02 |
GLU: Glucose. TG: Triglyceride. TC: Total cholesterol. BUN: Blood urea nitrogen. TP: Total protein. TBIL: Total Bilirubin. Statistical comparisons are indicated with a different superscript (a–f) in the same row (p < 0.05, *ANOVA and Tukey’s post-hoc test).
Figure 3Effects of Carnipure tartrate supplementation on L-carnitine plasma levels. The effects of Carnipure® tartrate on the total (A) free (B) and acyl (C) carnitine levels in exercised rats but also in non-exercised rats (groups C0 and C200). Statistical comparisons are indicated with a different superscript (a-g) in the plots (p < 0.05, ANOVA, and Tukey’s post-hoc test). The data in the box and whiskers graphics are presented as the median, minimum, and maximum values for each plot.
Safety parameters.
| Items | Groups | |||||||
|---|---|---|---|---|---|---|---|---|
| Control | Car200 | Exercise (E) | E+Car25 | E+Car50 | E+Car100 | E+Car200 | E+Car400 | |
| ALB, g/dL | 3.40 ± 0.08 | 3.46 ± 0.05 | 3.47 ± 0.09 | 3.23 ± 0.16 | 3.09 ± 0.21 | 3.56 ± 0.05 | 3.39 ± 0.07 | 3.44 ± 0.06 |
| GLOB, g/dL | 3.04 ± 0.12 b | 3.10 ± 0.08 a,b | 3.41 ± 0.10 a,b | 3.27 ± 0.11 a,b | 3.29 ± 0.12 a,b | 3.53 ± 0.11 a | 3.11 ± 0.11 a,b | 3.16 ± 0.05 a,b |
| ALT, U/L | 103.43 ± 5.12 | 100.86 ± 4.07 | 99.43 ± 3.73 | 100.00 ± 4.62 | 101.00 ± 3.13 | 99.57 ± 4.49 | 104.86 ± 4.40 | 100.14 ± 2.96 |
| AST, U/L | 121.78 ± 6.73 | 122.94 ± 7.48 | 121.68 ± 3.64 | 121.31 ± 5.17 | 120.50 ± 3.77 | 122.57 ± 3.29 | 122.57 ± 3.72 | 121.57 ± 4.95 |
ALB: Albumin. GLOB: Globulin. ALT: Alanine aminotransferase. AST: Aspartate aminotransferase. ALP: Alkaline phosphatase. Statistical comparisons are indicated with different superscripts (a–b) in the same row (p < 0.05, *ANOVA, and Tukey’s post-hoc test).